Skip navigation

J&J's DePuy to end 2 hip replacement systems

Johnson & Johnson's DePuy orthopedics business plans to stop selling a couple of hip replacement systems not widely used by doctors. Full story

Baby of the Week: Maliah Ayanna Davis

   TODAY’s Sara Haines introduces the latest adorable additions to Johnson & Johnson’s “Baby of the Week” segment.

Shareholders criticize J&J management for lapses

Several Johnson & Johnson shareholders took the health care giant to task during its annual meeting Thursday, criticizing management for repeated product recalls, ethical lapses and excessive executive pay. Full story

Johnson & Johnson CEO Shares 2013 Outlook

   Alex Gorksy, Johnson & Johnson chairman & CEO, offers insight on the firm's quarter and forecast for the year ahead.

Top 3 Trades

   Shares of Target are lower after the retailer warned its Q1 earnings would miss expectations, and Johnson & Johnson is up after reporting strong earnings, with the FMHR traders.

Earnings Scorecard Update: JNJ, GS, & GWW

   The "Squawk on the Street" news crew takes a closer look at three companies reporting first quarter numbers; including Johnson & Johnson, W.W. Grainger, and Goldman Sachs.

Sponsored Links

Articles

FDA approves Johnson & Johnson diabetes drug, canagliflozin

Jury awards $3.35 million in vaginal mesh case against Johnson & Johnson

Johnson & Johnson says its marketing practices being investigated

Johnson & Johnson recalls more metal hip implants

Johnson & Johnson beats forecast, takes new charge for recalled hips

Video

  Johnson & Johnson Hits All-Time High

Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.

  Three Stocks Positioned to Deliver: Expert

David Darst, Morgan Stanley Wealth Management, explains why he is positive on Johnson & Johnson, Schlumberger, and Microsoft.

  Baby boom! Check out this week’s adorable pics

Every week, with the help of Johnson & Johnson, TODAY’s Fourth Hour brings you the cutest, most adorable baby photos submitted to us by loving parents.

  Johnson & Johnson to pay $8.3 million for faulty hip implant

A jury has awarded more than $8 million to a man who accused a subsidiary of Johnson & Johnson of knowingly marketing a defective hip replacement that was later recalled. NBC’s Brian Williams reports.

  March 8: Nightly News Friday broadcast

Has the economy turned the corner?; Sequestration a symptom of Washington dysfunction; Conclave to begin Tuesday; Oceanfront home rips off its foundation; Chavez funeral brings dignitaries from around the world; European weather forecasts superior to US models; Ashley Judd may run for U.S. Senate; J

advertisement | ad info

Related Photos

A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster
A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster

A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado April 14, 2009. REUTERS/Rick Wilking

File photo of products made by Johnson & Johnson for sale on a store shelf in Westminster
File photo of products made by Johnson & Johnson for sale on a store shelf in Westminster

Products made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado in this April 14, 2009, file photo. Johnson & Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that had be

File photo of a first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster
File photo of a first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster

A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado in this April 14, 2009, file photo. Johnson & Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that